Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy Optimizing Research of Lamivudine Therapy (EXPLORE)

This study has been completed.
Sponsor:
Collaborators:
Major Science and Technology Special Project of China Eleventh Five-year
GlaxoSmithKline
Information provided by (Responsible Party):
Nanfang Hospital of Southern Medical University
ClinicalTrials.gov Identifier:
NCT01088009
First received: March 15, 2010
Last updated: October 28, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)